Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,447 stories, page 149 of 608

Advanced search

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

BofA makes bullish call on newly public biotech stock

thestreet.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Robbins LLP Urges AARD Stockholders Who Lost Money Investing in Aardvark Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action

MorningstarOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd (TEVA) Shares Fall 3.1% -- What GF Score of 47 Tells Investors

GuruFocusOriginal source

🇪🇸Aug 29Researchcnic.esTier 2 · Direct publisher

NEJM: REACT revela que la aterosclerosis silenciosa afecta ya a 1 de cada 13 jóvenes de entre 18 y 29 años y progresa rápidamente tras la menopausia

CNIC Spain CardiovascularOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

'Without guardrails': Abortion pill report exposes stunning lack of accountability

liveaction.orgOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Inebilizumab Reduces Exacerbations in gMG: MINT Trial Analysis

The American Journal of Managed CareOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Melanoma Vaccine Data Breakthrough: Moderna Receives Fifth Analyst Upgrade in Five Days

finance.biggo.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech expands PrePsia patent portfolio to nine patents

Investing.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Total revenue of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (NASDAQ: TRIB) moves to keep Nasdaq listing

Stock TitanOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech Updates on Commercial Progress, Manufacturing Transformation, PrePsia Patent Expansion and Nasdaq Compliance

Quiver QuantitativeOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

United Kingdom Silicone Tubing for Pharmaceutical Transfer - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update

marketscreener.comOriginal source

🌍Aug 29Associationkff.orgTier 2 · Direct publisher

KFF Survey Methodology & Data Collection Standards

KFF (Kaiser Family Foundation) HealthOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?

Yahoo FinanceOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

MarketWatchOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Dilution adjustment of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Net margin % of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Return on invested capital % of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Non-operating income (total) of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Gross margin % of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (TRIB) pulls 675M unsold shares from $25M standby deal

Stock TitanOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

FDA issues untitled letter to Alar for false advertising of investigational drug

RAPSOriginal source

🇺🇸Aug 29Researchrarediseases.orgTier 2 · Direct publisher

Tribute to Senator Kassebaum Baker

NORD Rare DiseasesOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Coronavirus: German/US vaccine candidate cleared for Phase 2 and 3 clinical trials

The Guardian Nigeria NewsOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Drug Companies, Prescribers Endanger Patients by Routinely Flouting FDA Rules, Senate Probe Finds

National ReviewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Sapablursen lowers need for blood draws in polycythemia vera

Rare Cancer NewsOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Net income of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Discontinued operations of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Biohacking party grounded in Koramangala: Karnataka FDA scuttles India's first "Peptide Party"

ANI NewsOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Total assets of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Total debt of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology

NewMediaWireOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Tech bills of the week: identifying sponsored content in AI tools; Reshoring biotech manufacturing; and more

Nextgov/FCWOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Dolly's Cancer Death; Mammogram Safety Alert; Chemo Drug Shortage Worsens

MedPage TodayOriginal source

🌍Aug 29discoverynews.google.comTier 2 · Trade media

Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction

Pharmaceutical TechnologyOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Cipla Pune Unit's Drug Sale Licence Cancelled Over 'Irregularities'

NDTVOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Bengaluru peptide party called off after Food Safety and Drug Administration notice

The Times of IndiaOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Bengaluru peptide party called off as FDA inspects company

The Times of IndiaOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

White House to Announce New Drug‑Pricing Deals With Biotechs, Prices Drop at Record Pace

Forth.NewsOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Total debt per share of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Pretax income of HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares – KRX:0479201G

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

HLB PHARMACEUTICAL CO., LTD. Rights 2026-11.08.26 For Shares

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels drug sale licence of Cipla's Pune unit

CityairnewsOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

FDA cancels drug sale licence of Cipla Pharma & Life Sciences's Pune Carry and Forwarding unit

ETLegalWorld.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

DualityBio and Teva Strike Major Biopharma Deals | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels licence of prominent pharma company in Pune

Big News Network.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla's Pune unit's drug sale licence

The New Indian ExpressOriginal source

🌍Aug 29discoverynews.google.comTier 2 · Trade media

Myasthenia gravis market to reach $13.0bn across 7MM by 2034

Pharmaceutical TechnologyOriginal source

🌍Aug 29discoverynews.google.comTier 2 · Trade media

MSD’s Lipfendra takes on injectable rivals for cholesterol-lowering market supremacy

Pharmaceutical TechnologyOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

FDA COMMISSIONER TUKARAM MUNDHE DRUG SAFETY PUBLIC HEALTH

DNA IndiaOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Price to book forward of EASTGATE BIOTECH CORP – OTC:ETBI

TradingViewOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Wells Fargo & Company Forecasts Strong Price Appreciation for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock

MarketBeatOriginal source

🌍Aug 29Industryeledon.comTier 1 · Company source

This Biotech CEO Is Creating A Cure For Type 1 Diabetes -Meet The CEO Of Eledon Pharma – $ELDN

Eledon PharmaceuticalsOriginal source